![Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Österreich Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Österreich](https://www.ypsomed.com/files/media/02_Images/09_Press_Releases/Ajovy_Pen_CMYK_DE_ohneSchatten_low.png)
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Österreich
Muhammad Abu Ahmad on LinkedIn: The TEVA class 2023's national forum for Bio-Innovators has officially…
![Teva Europe on X: "Teva's Christoph Stoller opened #VAW19 in Brussels today with an address to attendees on how we as a healthcare community can contribute to healthier societies. https://t.co/bL6jrhWZ86" / X Teva Europe on X: "Teva's Christoph Stoller opened #VAW19 in Brussels today with an address to attendees on how we as a healthcare community can contribute to healthier societies. https://t.co/bL6jrhWZ86" / X](https://pbs.twimg.com/media/EJ5SgFQXUAMjG-G.jpg)
Teva Europe on X: "Teva's Christoph Stoller opened #VAW19 in Brussels today with an address to attendees on how we as a healthcare community can contribute to healthier societies. https://t.co/bL6jrhWZ86" / X
![Shaping the future of caregiving: Dr. Markus Leyck Dieken, General Manager Teva Germany/Austria - YouTube Shaping the future of caregiving: Dr. Markus Leyck Dieken, General Manager Teva Germany/Austria - YouTube](https://i.ytimg.com/vi/ciQoFXcl6cY/hqdefault.jpg)
Shaping the future of caregiving: Dr. Markus Leyck Dieken, General Manager Teva Germany/Austria - YouTube
![Novartis v. Teva: Patent rivalries meet again, this time on a non-negligible injunction. - The IPKat Novartis v. Teva: Patent rivalries meet again, this time on a non-negligible injunction. - The IPKat](https://2.bp.blogspot.com/-sRfK6UDUTRQ/WzZsaQocDqI/AAAAAAAAADY/1jzaJ_0n7RYxh_vgSs5lJxPkH3rl_3ovgCLcBGAs/s1600/Exforge-Tablets-5mg_80mg-Front.png)